F19.96 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder

Name of the Condition

• Other Psychoactive Substance Use, Unspecified with Psychoactive Substance-Induced Persisting Amnestic Disorder
• ICD-10 Code: F19.96

Summary

This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and it is complicated by a persisting amnestic disorder. The amnestic disorder is a direct result of the substance’s effects on memory, leading to ongoing difficulties with recall or new learning.

Causes

The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. The amnestic disorder arises from the substance’s neurotoxic effects on brain regions involved in memory.

Risk Factors

• Peer pressure or cultural acceptance of substance use.
• Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
• Availability of and access to psychoactive substances.
• Prolonged or high-dose use of unidentified psychoactive agents.

Symptoms

Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. The amnestic disorder-specific symptoms include difficulty forming new memories, gaps in recall of recent events, or confusion. The exact presentation depends on the unidentified psychoactive agent.

Diagnosis

Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. Neurological or neuropsychological testing can help confirm the amnestic disorder and rule out other causes.

Treatment Options

• Counseling and Behavioral Therapies: Aim to address substance use and support cognitive recovery.
• Medication Management: May include treatments for co-occurring symptoms or withdrawal.
• Cognitive Rehabilitation: Focuses on improving memory and learning skills.

Prognosis and Follow-Up

Prognosis depends on the severity of the amnestic disorder and the patient’s response to treatment. Some memory deficits may persist long-term, while others may improve with abstinence and therapy. Regular follow-up is important to monitor cognitive function and substance use.

Complications

• Persistent memory impairment affecting daily functioning.
• Increased risk of accidents or injuries due to cognitive deficits.
• Potential for co-occurring mental health disorders.

Lifestyle & Prevention

• Avoiding unidentified psychoactive substances.
• Engaging in cognitive exercises to support memory.
• Seeking support for substance use to prevent further neurological damage.

When to Seek Professional Help

Seek help if memory problems interfere with daily life, or if substance use continues despite negative consequences. Early intervention may improve outcomes for both the substance use and amnestic disorder.

Tips for Medical Coders

Document the presence of the amnestic disorder and its link to the unspecified psychoactive substance use. Ensure the code F19.96 is used when the substance is not identified and the amnestic disorder is directly induced by the substance. Include details on the duration and severity of symptoms to support accurate coding.